CO4950564A1 - Nuevo proceso para la preparacion de una sustancia farmaco- logimante activa - Google Patents
Nuevo proceso para la preparacion de una sustancia farmaco- logimante activaInfo
- Publication number
- CO4950564A1 CO4950564A1 CO98026855A CO98026855A CO4950564A1 CO 4950564 A1 CO4950564 A1 CO 4950564A1 CO 98026855 A CO98026855 A CO 98026855A CO 98026855 A CO98026855 A CO 98026855A CO 4950564 A1 CO4950564 A1 CO 4950564A1
- Authority
- CO
- Colombia
- Prior art keywords
- racemic
- optically active
- general formula
- compounds
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cephalosporin Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Un proceso para la preparación de compuestos racémicos uópticamente activos con la fórmula general (VI)- en los que X representa un átomo de halógeno - o sus sales, caracterizado porque se transforma un nuevo compuesto racémico u ópticamente activo con la fórmula general (VII)- en el que X representa un átomo de halógeno - en el compuesto racémico u ópticamente activo con la fórmula general (VIII) - en el que X representa un átomo de halógeno - y, si se desea, los compuestos racémicos resultantes con la fórmula general (VIII) se resuelven en sus isómeros ópticamente activos y, luego, mediante un cierre de anillo, a través de un método conocido per se, los compuestos con la fórmula general (VIII) se transforman en los compuestos racémicos u ópticamente activos con la fórmula general (VI), y, si se desea, los compuestos racémicos u ópticamente activos con la fórmula general (VI) se resuelven en sus isómeros ópticos y/o se transforman en sus sales y/o el compuesto racémico u ópticamente activo es liberado desde sus sales.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9700885A HU222283B1 (hu) | 1997-05-13 | 1997-05-13 | Eljárás tieno[3,2-c]piridin-származékok előállítására |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4950564A1 true CO4950564A1 (es) | 2000-09-01 |
Family
ID=90014236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO98026855A CO4950564A1 (es) | 1997-05-13 | 1998-05-13 | Nuevo proceso para la preparacion de una sustancia farmaco- logimante activa |
Country Status (38)
| Country | Link |
|---|---|
| US (1) | US6180793B1 (es) |
| EP (1) | EP0981529B1 (es) |
| KR (1) | KR100428238B1 (es) |
| CN (1) | CN1109036C (es) |
| AR (1) | AR014349A1 (es) |
| AT (1) | ATE212025T1 (es) |
| AU (1) | AU735702B2 (es) |
| BR (1) | BR9809112B1 (es) |
| CA (1) | CA2289623C (es) |
| CO (1) | CO4950564A1 (es) |
| CZ (1) | CZ292820B6 (es) |
| DE (1) | DE69803176T2 (es) |
| DK (1) | DK0981529T3 (es) |
| DZ (1) | DZ2487A1 (es) |
| EE (1) | EE03925B1 (es) |
| EG (1) | EG21973A (es) |
| ES (1) | ES2172141T3 (es) |
| HK (1) | HK1027350A1 (es) |
| HR (1) | HRP980240B1 (es) |
| HU (1) | HU222283B1 (es) |
| ID (1) | ID23018A (es) |
| IL (1) | IL132774A0 (es) |
| IS (1) | IS1883B (es) |
| ME (1) | ME01636B (es) |
| MY (1) | MY121299A (es) |
| NO (1) | NO325419B1 (es) |
| NZ (1) | NZ501577A (es) |
| PL (1) | PL194859B1 (es) |
| PT (1) | PT981529E (es) |
| RS (1) | RS49626B (es) |
| RU (1) | RU2172315C1 (es) |
| SA (1) | SA98190583B1 (es) |
| SK (1) | SK283700B6 (es) |
| TR (1) | TR199902783T2 (es) |
| TW (1) | TW552263B (es) |
| UA (1) | UA66359C2 (es) |
| WO (1) | WO1998051689A1 (es) |
| ZA (1) | ZA983921B (es) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2769313B1 (fr) * | 1997-10-06 | 2000-04-21 | Sanofi Sa | Derives d'esters hydroxyacetiques, leur procede de preparation et leur utilisation comme intermediaires de synthese |
| HU226421B1 (en) | 1998-11-09 | 2008-12-29 | Sanofi Aventis | Process for racemizing optically active 2-(2-chlorophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides |
| IN191030B (es) * | 2001-01-24 | 2003-09-13 | Cadila Healthcare Ltd | |
| US6495691B1 (en) | 2001-07-06 | 2002-12-17 | Brantford Chemicals Inc. | Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives |
| US6767913B2 (en) | 2001-12-18 | 2004-07-27 | Teva Pharmaceutical Industries Ltd. | Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms |
| US7074928B2 (en) | 2002-01-11 | 2006-07-11 | Teva Pharmaceutical Industries, Ltd. | Polymorphs of clopidogrel hydrogensulfate |
| ITMI20020933A1 (it) * | 2002-05-03 | 2003-11-03 | Danimite Dipharma S P A | Procedimento per la sintesi di clopidogrel |
| US6800759B2 (en) * | 2002-08-02 | 2004-10-05 | Teva Pharmaceutical Industries Ltd. | Racemization and enantiomer separation of clopidogrel |
| IL166593A0 (en) | 2002-08-02 | 2006-01-15 | Racemization and enantiomer separation of clopidogrel | |
| US6812363B2 (en) * | 2002-10-15 | 2004-11-02 | Usv Limited | Racemization of optically active 2-substituted phenyl glycine esters |
| US20060100231A1 (en) * | 2003-03-10 | 2006-05-11 | Hetero Drugs Limited | Amorphous clopidogrel hydrogen sulfate |
| AU2003238664A1 (en) | 2003-03-12 | 2004-09-30 | Cadila Healthcare Limited | Polymorphs and amorphous form of (s) - (+) -clopidogrel bisulfate |
| GB0321256D0 (en) * | 2003-09-11 | 2003-10-08 | Generics Uk Ltd | Novel crystalline compounds |
| EP2103617A1 (en) | 2003-11-03 | 2009-09-23 | Cadila Healthcare Limited | Processes for preparing different forms of (S)-(+)-clopidogrel bisulfate |
| CA2457459A1 (en) * | 2004-02-11 | 2005-08-11 | Brantford Chemicals Inc. | Resolution of racemates of methyl alpha-5-(4,5,6,7-tetrahydro(3,2-c)thienopyridyl)-(2-chlorophenyl) acetate |
| KR100553398B1 (ko) | 2004-03-12 | 2006-02-16 | 한미약품 주식회사 | 티에노[3,2-ｃ]피리딘 유도체의 제조 방법 및 이에사용되는 중간체 |
| US20060154957A1 (en) * | 2004-09-21 | 2006-07-13 | Nina Finkelstein | Crystalline clopidogrel hydrobromide and processes for preparation thereof |
| TW200640932A (en) * | 2005-02-24 | 2006-12-01 | Teva Pharma | Clopidogrel base suitable for pharmaceutical formulation and preparation thereof |
| KR100681512B1 (ko) | 2005-03-08 | 2007-02-09 | 주식회사 한서켐 | 클로피도그렐의 신규한 제조 중간체 및 이를 이용한 클로피도그렐의 제조방법 |
| KR101235117B1 (ko) | 2005-12-26 | 2013-02-20 | 에스케이케미칼주식회사 | 광학분리에 의한 (ｓ)-(＋)-클로피도그렐의 제조방법 |
| RU2008146758A (ru) * | 2006-04-27 | 2010-06-10 | Инд-Свифт Лэборетриз Лимитед (In) | Способ получения полиморфных форм клопидогрела гидросульфата |
| WO2008019053A2 (en) * | 2006-08-03 | 2008-02-14 | Teva Pharmaceutical Industries Ltd. | Process for preparing clopidogrel bisulphate |
| ES2359851T3 (es) | 2006-09-04 | 2011-05-27 | Ranbaxy Laboratories Limited | Proceso mejorado para la preparación de clopidogrel y sus sales farmaceuticamente aceptables. |
| EP1980563A1 (en) | 2007-04-09 | 2008-10-15 | BATTULA, Srinivasa Reddy | Procedure for the preparation of methyl (+)-(S)-Alpha-(O-chlorophenyl)-6,7-dihydrothieno-[3,2-C]pyridine-5(4H) acetate |
| EP2107061A1 (en) | 2008-04-02 | 2009-10-07 | Krka Tovarna Zdravil, D.D., Novo Mesto | Process for the preparation of optically enriched clopidogrel |
| US20090264460A1 (en) * | 2008-04-21 | 2009-10-22 | Mamta Mishra | Clopidogrel pharmaceutical formulations |
| KR100990949B1 (ko) | 2008-06-09 | 2010-10-29 | 엔자이텍 주식회사 | 클로피도그렐 및 그의 유도체의 제조방법 |
| WO2010046476A1 (en) * | 2008-10-24 | 2010-04-29 | Sandoz Ag | A process for the preparation of s-clopidogrel |
| US8563690B2 (en) * | 2008-11-03 | 2013-10-22 | The Board Of Trustees Of The University Of Illinois | Modulation of platelet aggregation |
| CN101544655B (zh) * | 2009-05-05 | 2012-07-04 | 上海医药集团股份有限公司 | 噻吩并[3，2-c]吡啶衍生物的制备方法 |
| CN101863899B (zh) * | 2010-06-21 | 2013-03-20 | 常州制药厂有限公司 | 一种提高氯吡格雷樟脑磺酸盐拆分收率的方法 |
| KR20170004282A (ko) | 2015-07-02 | 2017-01-11 | 류종렬 | 수도 지지부가 구비된 쉐이크 핸드형 탁구 라켓 |
| KR20170004283A (ko) | 2015-07-02 | 2017-01-11 | 류종렬 | 그립부가 개선된 쉐이크 핸드형 탁구 라켓 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2530247B1 (fr) * | 1982-07-13 | 1986-05-16 | Sanofi Sa | Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique |
| FR2608607B1 (fr) | 1986-12-23 | 1989-04-28 | Sanofi Sa | Procede de preparation de thienylethylamines et dithienylethylamines ainsi obtenues |
| FR2623810B2 (fr) * | 1987-02-17 | 1992-01-24 | Sanofi Sa | Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant |
| FR2652575B1 (fr) * | 1989-09-29 | 1992-01-24 | Sanofi Sa | Procede de preparation d'acides alpha-bromo phenylacetiques. |
| FR2664596B1 (fr) | 1990-07-10 | 1994-06-10 | Sanofi Sa | Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese. |
-
1997
- 1997-05-13 HU HU9700885A patent/HU222283B1/hu active IP Right Grant
-
1998
- 1998-05-06 HR HR980240A patent/HRP980240B1/xx not_active IP Right Cessation
- 1998-05-08 ZA ZA983921A patent/ZA983921B/xx unknown
- 1998-05-11 KR KR10-1999-7010466A patent/KR100428238B1/ko not_active IP Right Cessation
- 1998-05-11 US US09/423,549 patent/US6180793B1/en not_active Expired - Lifetime
- 1998-05-11 DE DE69803176T patent/DE69803176T2/de not_active Expired - Lifetime
- 1998-05-11 CZ CZ19993939A patent/CZ292820B6/cs not_active IP Right Cessation
- 1998-05-11 PL PL336693A patent/PL194859B1/pl unknown
- 1998-05-11 AT AT98921670T patent/ATE212025T1/de active
- 1998-05-11 BR BRPI9809112-3A patent/BR9809112B1/pt not_active IP Right Cessation
- 1998-05-11 IL IL13277498A patent/IL132774A0/xx not_active IP Right Cessation
- 1998-05-11 RU RU99126506/04A patent/RU2172315C1/ru active
- 1998-05-11 PT PT98921670T patent/PT981529E/pt unknown
- 1998-05-11 CN CN98805036A patent/CN1109036C/zh not_active Expired - Lifetime
- 1998-05-11 RS YUP-587/99A patent/RS49626B/sr unknown
- 1998-05-11 SK SK1516-99A patent/SK283700B6/sk not_active IP Right Cessation
- 1998-05-11 ES ES98921670T patent/ES2172141T3/es not_active Expired - Lifetime
- 1998-05-11 CA CA002289623A patent/CA2289623C/en not_active Expired - Fee Related
- 1998-05-11 TR TR1999/02783T patent/TR199902783T2/xx unknown
- 1998-05-11 DK DK98921670T patent/DK0981529T3/da active
- 1998-05-11 WO PCT/HU1998/000048 patent/WO1998051689A1/en active IP Right Grant
- 1998-05-11 AU AU74448/98A patent/AU735702B2/en not_active Expired
- 1998-05-11 ME MEP-1999-587A patent/ME01636B/me unknown
- 1998-05-11 EP EP98921670A patent/EP0981529B1/en not_active Expired - Lifetime
- 1998-05-11 NZ NZ501577A patent/NZ501577A/en not_active IP Right Cessation
- 1998-05-11 EE EEP199900488A patent/EE03925B1/xx unknown
- 1998-05-12 EG EG52098A patent/EG21973A/xx active
- 1998-05-12 MY MYPI98002116A patent/MY121299A/en unknown
- 1998-05-12 DZ DZ980098A patent/DZ2487A1/xx active
- 1998-05-13 AR ARP980102220A patent/AR014349A1/es active IP Right Grant
- 1998-05-13 CO CO98026855A patent/CO4950564A1/es unknown
- 1998-06-12 TW TW087109424A patent/TW552263B/zh not_active IP Right Cessation
- 1998-09-27 SA SA98190583A patent/SA98190583B1/ar unknown
- 1998-11-05 ID IDW991592A patent/ID23018A/id unknown
- 1998-11-05 UA UA99126785A patent/UA66359C2/uk unknown
-
1999
- 1999-11-11 IS IS5244A patent/IS1883B/is unknown
- 1999-11-12 NO NO19995533A patent/NO325419B1/no not_active IP Right Cessation
-
2000
- 2000-10-10 HK HK00106408A patent/HK1027350A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4950564A1 (es) | Nuevo proceso para la preparacion de una sustancia farmaco- logimante activa | |
| ES2132580T3 (es) | Derivados de aroil-piperidina. | |
| ES2147230T3 (es) | Derivados de aminoacidos, medicamentos que contienen a estos compuestos y procedimiento para su preparacion. | |
| EA199800140A1 (ru) | Композиции с контролируемым высвобождением пароксетина | |
| ES2190396T3 (es) | Nuevos compuestos amino-triazoles, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| PA8426801A1 (es) | Composiciones farmaceuticas para el tratamiento de la rinitis. | |
| DK1001036T3 (da) | Enzymatiske fremgangsmåder til spaltning af enantiomerblandinger af forbindelser, der er nyttige som mellemprodukter ved fremstillingen af taxaner | |
| ATE248153T1 (de) | Neue benzoxazole | |
| BR0011597A (pt) | Método para separar compostos orgânicos análogos e resina de troca iÈnica | |
| DK0912537T3 (da) | Fremgangsmåde til fremstilling af phenylheterocykliske forbindelser, der er anvendelige som cox-2-inhibitorer | |
| CO6140035A2 (es) | Derivados de bencimidazol 5-sulfonamida como ligandos del receptor cannabinoide 1 (cb1) | |
| ECSP045498A (es) | "difenilazetidinonas sustituidas en anillo, metodo para su producción, medicamentos que comprenden estos compuestos y su uso" | |
| CO5601045A2 (es) | Procedimiento para la fabricacion de compuestos organicos | |
| ES477520A1 (es) | Procedimiento para la preparacion de nuevas penicilinas. | |
| CO5720995A2 (es) | Compuesto novedoso | |
| DK1027348T3 (da) | 2-(2'-hydroxyphenyl)benzotriazoler anvendt som UV-stabilisatorer | |
| NO20016151L (no) | Fremstilling av substituerte piperidin-4-oner | |
| BRPI0411308A8 (pt) | Composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto | |
| BR9507381A (pt) | Composto uso de um composto processo para o tratamento de um manifero composição famacèutica e processo para a preparação de compostos | |
| ES2146041T3 (es) | Procedimiento de preparacion de acidos carboxilicos alfa,beta-no saturados. | |
| ES2183492T3 (es) | Nuevos derivados de nitrono,su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| ES2179529T3 (es) | Compuestos biaromaticos unidos por un radical heteroetinileno, y composiciones farmaceuticas y cosmeticas que los contienen. | |
| AR035489A1 (es) | 4-fenil-1-(1-fenil-ciclohexil)-1,2,3,6,-tetrahidropiridinas sustituidas, procedimientos para su preparacion, medicamentos que contienen estos compuestos y el uso de estas sustancias para la preparacion de medicamentos | |
| ES2190441T3 (es) | Procedimiento para la sintesis de inhibidores de hmg-coa reductasa. | |
| ES2189108T3 (es) | Nuevas oxazinas dissustituidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen. |